Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01993862 · ClinicalTrials.gov registry record · NA

Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Implant

A NA study of Heart Failure and Coronary Artery Disease, sponsored by Abbott Medical Devices.

Completed
Registry status
NA
Development phase
266
Enrollment target
20
Study locations

NCT01993862 is a NA study of Heart Failure and Coronary Artery Disease that has completed, run by Abbott Medical Devices. The registered enrollment target is 266 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (87% lower). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01993862, a NA study of Heart Failure and Coronary Artery Disease, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
NA
Development phase
266 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine whether it is safe to send patients home from the hospital on the same day following an implantable cardioverter defibrillator (ICD) implant.

Conditions Studied

Heart Failure Coronary Artery Disease

Interventions

  • OTHER Same Day Discharge

Study Locations (20)

California

  • Chula Vista Cardiac Center - Chula Vista
  • Cardiovascular Consultants Heart Center - Fresno
  • Stanislaus Cardiology Group - Modesto
  • Sutter Medical Center of Santa Rosa - Santa Rosa

Florida

  • Lakeland Regional Medical Center - Lakeland
  • Watson Clinic Center - Lakeland
  • Florida Cardiovascular Specialists - Leesburg
  • Naples Heart Rhythm Specialists, PA - Naples

Alabama

  • Heart Center Research - Huntsville
  • Cardiology Associates of Mobile - Mobile

Colorado

  • Exempla Rocky Mountain Cardiovascular Associates - Broomfield
  • South Denver Cardiology Associates PC - Littleton

Illinois

  • Loyola University Medical Center - Maywood
  • Chicago Cardiology Institute - Schaumburg

Michigan

  • Thoracic Cardiovascular Healthcare Foundation - Lansing
  • Great Lakes Heart and Cascular Institute PC - Saint Joseph

Arizona

  • John C Lincoln North Mountain Hospital - Phoenix

Louisiana

  • Ochsner Medical Center - New Orleans

Trial Details

FieldValue
Enrollment Target 266 participants
Start Date 2014-03-17
Est. Completion 2016-08-12
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01993862

The ClinicalTrials.gov registry entry for NCT01993862 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (87% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Same Day Discharge is the first listed.

NCT01993862 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Florida, Alabama.

Frequently Asked Questions

What is clinical trial NCT01993862 about?

NCT01993862 is a clinical study titled "Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Implant". The purpose of this study is to determine whether it is safe to send patients home from the hospital on the same day following an implantable cardioverter defibrillator (ICD) implant.

What is the current status of trial NCT01993862?

This trial is currently completed. It is a NA study. The enrollment target is 266 participants. The study started on 2014-03-17. Estimated completion is 2016-08-12.

What conditions does trial NCT01993862 study?

This clinical trial studies the following conditions: Heart Failure, Coronary Artery Disease.

What interventions are being tested in trial NCT01993862?

The interventions under investigation include: Same Day Discharge (OTHER).

Who is sponsoring clinical trial NCT01993862?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01993862 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure

All registered trials for this condition

Coronary Artery Disease

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.